DE60331724D1 - Verwendung von bestimmten lösungsmitteln zur herstellung von bisphosphonsäuren - Google Patents

Verwendung von bestimmten lösungsmitteln zur herstellung von bisphosphonsäuren

Info

Publication number
DE60331724D1
DE60331724D1 DE60331724T DE60331724T DE60331724D1 DE 60331724 D1 DE60331724 D1 DE 60331724D1 DE 60331724 T DE60331724 T DE 60331724T DE 60331724 T DE60331724 T DE 60331724T DE 60331724 D1 DE60331724 D1 DE 60331724D1
Authority
DE
Germany
Prior art keywords
preparation
bisphosphonic acids
certain solvents
acid
diluent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60331724T
Other languages
English (en)
Inventor
Rami Lidor-Hadas
Zvi Harel
Revital Lifshitz-Liron
Eti Kovalevski-Liron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Application granted granted Critical
Publication of DE60331724D1 publication Critical patent/DE60331724D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60331724T 2002-05-17 2003-05-19 Verwendung von bestimmten lösungsmitteln zur herstellung von bisphosphonsäuren Expired - Fee Related DE60331724D1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US38128402P 2002-05-17 2002-05-17
US40131302P 2002-08-06 2002-08-06
US42333702P 2002-11-01 2002-11-01
US43183802P 2002-12-09 2002-12-09
US45019303P 2003-02-25 2003-02-25
PCT/US2003/015676 WO2003097655A1 (en) 2002-05-17 2003-05-19 Use of certain diluents for making bisphosphonic acids

Publications (1)

Publication Number Publication Date
DE60331724D1 true DE60331724D1 (de) 2010-04-29

Family

ID=29554537

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60331724T Expired - Fee Related DE60331724D1 (de) 2002-05-17 2003-05-19 Verwendung von bestimmten lösungsmitteln zur herstellung von bisphosphonsäuren

Country Status (12)

Country Link
US (3) US7038083B2 (de)
EP (1) EP1476451B1 (de)
JP (1) JP3857706B2 (de)
KR (1) KR100681282B1 (de)
CN (1) CN1665825A (de)
AT (1) ATE461205T1 (de)
AU (1) AU2003233569A1 (de)
CA (2) CA2657002A1 (de)
DE (1) DE60331724D1 (de)
IL (1) IL165227A0 (de)
PL (1) PL373574A1 (de)
WO (1) WO2003097655A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1620284B (zh) 2001-12-24 2010-04-28 特瓦制药工业有限公司 含有用粉末或粒状材料的压缩环状体包鞘的有效成分片芯的剂型,及其生产工艺和工具
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
JP3857706B2 (ja) * 2002-05-17 2006-12-13 テバ ファーマシューティカル インダストリーズ リミティド ビスホスホン酸作製のための特定の希釈剤の使用
CA2536229C (en) 2003-08-21 2012-09-25 Sun Pharmaceutical Industries Limited A process for preparation of bisphosphonic acid compounds
DE602004032577D1 (de) * 2003-12-23 2011-06-16 Alchymars S P A Amorphe Form das Natriumsalzes der Ibandronsäure
WO2005063717A1 (en) * 2003-12-26 2005-07-14 Natco Pharma Limited An improved process for the preparation of zoledronic acid
WO2006002348A2 (en) * 2004-06-23 2006-01-05 Teva Pharmaceutical Industies Ltd. Solid and crystalline ibandronic acid
WO2008128056A1 (en) 2004-10-08 2008-10-23 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps
US7687482B2 (en) 2006-03-17 2010-03-30 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods
US7358361B2 (en) 2004-10-08 2008-04-15 The Board Of Trustees Of The University Of Illinois Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
US7214818B2 (en) * 2004-10-29 2007-05-08 Hoffmann-La Roche Inc. Method for synthesizing bisphosphonate
PL199215B1 (pl) * 2004-12-28 2008-08-29 Politechnika Gdanska Sposób wytwarzania kwasu [1-hydroksy-2-(3-pirydylo)etylidenobisfosfonowego] oraz jego soli monosodowej dwu i pół wodnej
WO2006134603A1 (en) 2005-06-13 2006-12-21 Jubilant Organosys Limited Process for producing bisphosphonic acids and forms thereof
US8003820B2 (en) 2005-10-20 2011-08-23 Dr. Reddy's Laboratories Limited Process for preparing bisphosphonic acids
EP1963345A2 (de) * 2005-12-16 2008-09-03 Wockhardt Limited Verfahren zur herstellung reiner zoledronsäure
WO2007083240A2 (en) 2006-01-20 2007-07-26 Aurobindo Pharma Limited An improved process for the preparation of bisphosphonic acids
WO2007127249A1 (en) * 2006-04-25 2007-11-08 Teva Pharmaceutical Industries Ltd. Crystalline forms of ibandronic acid and processes for preparation thereof
WO2007125521A2 (en) * 2006-05-02 2007-11-08 Ranbaxy Laboratories Limited Polymorphic form of zoledronic acid and processes for their preparation
JP5354858B2 (ja) * 2006-05-09 2013-11-27 株式会社Adeka スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物
US8076483B2 (en) * 2006-05-11 2011-12-13 M/S. Ind Swift Laboratories Limited Process for the preparation of pure risedronic acid or salts
WO2008044245A2 (en) * 2006-10-10 2008-04-17 Matrix Laboratories Ltd A process for the preparation of risedronate sodium hemipentahydrate
CA2570949A1 (en) * 2006-12-12 2008-06-12 Apotex Pharmachem Inc. Ibandronate sodium propylene glycol solvate and processes for the preparation thereof
BRPI0809548A8 (pt) * 2007-04-11 2018-10-16 Hoffmann La Roche processo para a preparação do sal ácido- (mono-hidratado)-3- (n-metil-n-pentil) amino-1-hidroxipropano-1, 1-difosfônico monossódico
US7605148B2 (en) * 2007-04-16 2009-10-20 Aurobindo Pharma Ltd. Aqueous oral solution of bisphosphonic acid
WO2008152518A2 (en) * 2007-05-16 2008-12-18 Actavis Group Ptc Ehf Process for the preparation of risedronic acid or risedronate sodium
WO2009050731A2 (en) * 2007-06-20 2009-04-23 Alkem Laboratories Ltd Novel process for preparing risedronic acid
KR100877667B1 (ko) 2007-06-28 2009-01-08 보령제약 주식회사 리세드로네이트의 제조 방법
WO2009034580A1 (en) * 2007-09-11 2009-03-19 Fleming Laboratories Limited Improved process for the preparation of risedronate sodium hemipentahydrate
JP5258370B2 (ja) * 2008-05-08 2013-08-07 ダイト株式会社 リセドロン酸の工業的製造方法
EP2310398A2 (de) * 2008-07-11 2011-04-20 Synthon B.V. Verfahren zur herstellung von 1-hydroxyalkyliden-1,1-biphosphonsäuren
PL213599B1 (pl) 2008-10-31 2013-03-29 Politechnika Gdanska Sposób otrzymywania kwasu [1-hydroksy-2-(1H-imidazol-1-ilo)-etylideno] bisfosfonowego
WO2010060619A1 (en) * 2008-11-26 2010-06-03 Synthon B.V. Process for making zoledronic acid
US20100130746A1 (en) * 2008-11-26 2010-05-27 Martin Kas Process for Making Zoledronic Acid
EP2192126B1 (de) 2008-11-26 2013-03-27 Synthon B.V. Verfahren zur Herstellung von Zoledronsäure
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
JP5852569B2 (ja) 2009-07-31 2016-02-03 タール ファーマシューティカルズ,インコーポレイテッド 結晶化方法および生物学的利用能
WO2011016738A1 (en) 2009-08-05 2011-02-10 Zaklady Farmaceutyczne Polpharma Sa A process for the synthesis of 1-hydroxy-3-(n-methylpentylamino) propylidene bisphosphonic acid monosodium salt, monohydrate
EA201270328A1 (ru) 2009-08-28 2012-09-28 Синтон Б. В. Способ получения 1-гидроксиалкилиден-1,1-дифосфоновых кислот
US8882740B2 (en) * 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
US9340565B2 (en) 2010-11-24 2016-05-17 Thar Pharmaceuticals, Inc. Crystalline forms
WO2017208070A1 (en) 2016-05-31 2017-12-07 Grünenthal GmbH Bisphosphonic acid and coformers with lysin, glycin, nicotinamide for treating psoriatic arthritis
EP3553067A1 (de) * 2018-04-10 2019-10-16 Abiogen Pharma S.p.A. Polymorph von natriumneridronat und herstellungsverfahren dafür

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3016289A1 (de) 1980-04-28 1981-10-29 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren
IT1201087B (it) * 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
IT1196315B (it) * 1984-10-29 1988-11-16 Gentili Ist Spa Procedimento per la preparazione di acidi difosfonici
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3700772A1 (de) 1987-01-13 1988-07-21 Inst Khim Kinetiki I Gorenija Verfahren zur herstellung von i-funktionellsubstituierten alkyliden-i,i-diphosphonsaeuren und deren gemischen
US4922007A (en) 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
US5039819A (en) * 1990-09-18 1991-08-13 Merck & Co., Inc. Diphosphonate intermediate for preparing an antihypercalcemic agent
US5159108A (en) * 1990-09-18 1992-10-27 Merck & Co., Inc. Process for preparing an antihypercalcemic agent
US5327490A (en) * 1991-02-19 1994-07-05 Intervoice, Inc. System and method for controlling call placement rate for telephone communication systems
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
US5510517A (en) * 1993-08-25 1996-04-23 Merck & Co., Inc. Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids
TW257765B (de) * 1993-08-25 1995-09-21 Merck & Co Inc
US5449819A (en) * 1994-06-06 1995-09-12 Merck & Co., Inc. Process for removing waste pox, alendronate and its by products
US5589691A (en) * 1994-06-06 1996-12-31 Merck & Co., Inc. Process for recovery and recycle of methanesulfonic acid and phosphorous acid
JP3349032B2 (ja) * 1996-03-15 2002-11-20 株式会社東芝 発呼制御方法
KR100192215B1 (ko) 1996-09-03 1999-06-15 강재헌 3-아미노-1-히드록시프로판-1,1-디포스폰산의 제조방법
CA2197267C (en) 1997-02-11 2000-02-08 Yong Tao Process for the production of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
ES2153794B1 (es) * 1999-08-06 2001-10-16 Medichem Sa Procedimiento para la obtencion del acido 4-amino-1-hidroxibutiliden-1,1-bisfosfonico y de su sal monosodica trihidratada.
PE20011065A1 (es) 2000-02-01 2001-11-21 Procter & Gamble Proceso para fabricar bisfosfonatos geminales
TR200101250A2 (tr) * 2001-05-10 2003-04-21 E�S Eczaciba�I �Zg�N K�Myasal �R�Nler Sanay� A.�. 4-amino-1-hidroksibutiliden-1,1-bifosfonik asit veya tuzlarının hazırlanmasına ilişkin proses
GB0115824D0 (en) * 2001-06-28 2001-08-22 Rhodia Cons Spec Ltd Improved solvent systems
US6645974B2 (en) * 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof
ITMI20020908A1 (it) * 2002-04-29 2003-10-29 Chemi Spa Processo di preparazione di sodio alendronato
JP3857706B2 (ja) * 2002-05-17 2006-12-13 テバ ファーマシューティカル インダストリーズ リミティド ビスホスホン酸作製のための特定の希釈剤の使用
HUP0300227A2 (hu) * 2003-01-28 2004-09-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás nagy tisztaságú 2-szubsztituált -1-(hidroxi-etilidén)-1,1-biszfoszfonsavak és sóik előállítására
CA2536229C (en) * 2003-08-21 2012-09-25 Sun Pharmaceutical Industries Limited A process for preparation of bisphosphonic acid compounds
DE602004032577D1 (de) * 2003-12-23 2011-06-16 Alchymars S P A Amorphe Form das Natriumsalzes der Ibandronsäure
US7361761B2 (en) * 2004-09-28 2008-04-22 Orchid Chemicals & Pharmaceuticals Ltd. Process for the preparation of bisphosphonic acid
US8003820B2 (en) * 2005-10-20 2011-08-23 Dr. Reddy's Laboratories Limited Process for preparing bisphosphonic acids
EP1803727B1 (de) * 2005-12-27 2009-03-11 IPCA Laboratories Limited Verbesserter Herstellungsprozess von 4-Amino-Hydroxybutyliden-1,1-bisphosphonischer Säure und ihrer Salze
WO2007083240A2 (en) * 2006-01-20 2007-07-26 Aurobindo Pharma Limited An improved process for the preparation of bisphosphonic acids
CA2642321A1 (en) * 2006-02-20 2007-08-30 Alembic Limited An improved process for the preparation of biphosphonic derivatives

Also Published As

Publication number Publication date
US7038083B2 (en) 2006-05-02
PL373574A1 (en) 2005-09-05
EP1476451A1 (de) 2004-11-17
KR100681282B1 (ko) 2007-02-12
EP1476451B1 (de) 2010-03-17
CA2485443A1 (en) 2003-11-27
CN1665825A (zh) 2005-09-07
CA2657002A1 (en) 2003-11-27
WO2003097655A1 (en) 2003-11-27
JP2005526140A (ja) 2005-09-02
AU2003233569A1 (en) 2003-12-02
US20090209763A1 (en) 2009-08-20
ATE461205T1 (de) 2010-04-15
KR20040111633A (ko) 2004-12-31
CA2485443C (en) 2010-04-06
IL165227A0 (en) 2005-12-18
US20060128960A1 (en) 2006-06-15
US20040043967A1 (en) 2004-03-04
JP3857706B2 (ja) 2006-12-13

Similar Documents

Publication Publication Date Title
DE60331724D1 (de) Verwendung von bestimmten lösungsmitteln zur herstellung von bisphosphonsäuren
ATE451380T1 (de) Verfahren zur herstellung von bisphosphonsäureverbindungen
DE60210772D1 (de) Verfahren zur herstellung von l-aminosäuren unter verwendung von stämmen der familie enterobacteriaceae
TW200626951A (en) Process for modifying offset voltage characteristics of an interferometric modulator
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
ATE506356T1 (de) Verfahren zur herstellung von 3-halo-4,5-dihydro- 1h-pyrazolen
DE60207328D1 (de) Verfahren zur Herstellung von Phosphorsäureestern
DE60329640D1 (de) Verfahren zur Herstellung von N-Monoalkyl-Beta-Aminoalkoholen
ATE310718T1 (de) Verfahren zur herstellung von (meth)acrylsäureanhydrid
DE60314730D1 (de) Verwendung von 4-aminopyrimidinen zur antimikrobiellen behandlung von oberflächen
ATE297937T1 (de) Verfahren zur herstellung von siliconverbindungen
DE60124289D1 (de) Verfahren zur herstellung von 21-hydroxy-6,19-oxidoprogesteron (21oh-6op)
DE50005649D1 (de) Verfahren zur Herstellung von Alkylphosphonsäuren
DE60239286D1 (de) Verfahren zur herstellung von trans-1,4-cyclohexandicarbonsäure
ATE327219T1 (de) Verfahren zur herstellung von hydroxymethylthiobuttersäure
DE50209620D1 (de) Verfahren zur Herstellung von kristallinem Cholinascorbat
DE60211695D1 (de) Verfahren zur herstellung von phosphorsäureestern
ATE389010T1 (de) Verfahren zur herstellung von optisch aktiven pyridinethanol-derivaten
DE60232878D1 (de) Unter biokompatiblen bedingungen verarbeitbare fotoresists zur erzeugung von biomolekül-mustern
DE502004009156D1 (de) Verfahren zur herstellung von mit phosphonsäureester modifizierten organosiloxanen
DE50109809D1 (de) Verfahren zur Herstellung von D- oder L-Menthol
DE10290206D2 (de) Verfahren zur Regelung der Fahrstabilität
DE50203388D1 (de) Verbessertes verfahren zur herstellung von bisphosphiten
ATE297478T1 (de) Verfahren zur herstellung von orthocarbonsäuretrialkylestern
EP1428893A3 (de) Verfahren und Zusammensetzungen zur Modulierung des Haarwachstums durch p-Cadherin-Modulatoren

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee